NGS diagnostics: from panel design to data analysis
Molecular Oncology Center
About Us
Since 2011, OncoAtlas advances precision oncology with commitment to scientific excellence, improving clinical practice by providing NGS solutions to labs, oncologists and cancer patients.
Our products encompass every stage of NGS, from panel design to data analysis using proprietary software, ensuring the highest standards for precision oncology diagnostics.
Our products encompass every stage of NGS, from panel design to data analysis using proprietary software, ensuring the highest standards for precision oncology diagnostics.
Our software enables automated analysis of NGS data and generates user-friendly genomic reports
Easy-to-use NGS kits for routine clinical practice
OncoAtlas provides full-stack solutions for precision oncology
We are collaborating with researchers to transform cancer care
OncoAtlas provides full-stack solutions for precision oncology
Easy-to-use NGS kits for routine clinical practice
Our software enables automated analysis of NGS data and generates user-friendly genomic reports
We are collaborating with researchers to transform cancer care
Software for data analysis and interpretation
oncoatlas
NGS
Library preparation
oncoatlas
OncoAtlas Solutions for Molecular Diagnostics
1 in 3
We are committed to transform cancer care by expanding access to NGS testing
6 500 000
Population of Siberia region where PCR for cancer genetics was completely replaced by OncoAtlas NGS tests
*according to our sales reports (calculations are based on cancer epidemiology statistics in Russia)
breast cancer patients in Russia is estimated to receive NGS test results through our solutions*
PCR
G
GCTACTGAGCTACTGAGCTACTGA
GCTACTGAGCTACTGAGCTACTGA
GCTACTGAGCTACTGAGCTACTGA
GCTACTGAGCTACTGAGCTACTGA
GCTACTGAGCTACTGAGCTACTGA
GCTACTGAGCTACTGAGCTACTGA
GCTACTGAGCTACTGAGCTACTGA
GCTACTGAGCTACTGAGCTACTGA
GCTACTGAGCTACTGAGCTACTGA
GCTACTGAGCTACTGAGCTACTGA
GCTACTGAGCTACTGAGCTACTGA
GCTACTGAGCTACTGAGCTACTGA
GCTACTGAGCTACTGAGCTACTGA
GCTACTGAGCTACTGAGCTACTGA
NGS
GCTACTGAGCTACTGAGCTACTGAGCTACTGAGCTACTGAGCTACTGA
Sanger
PIK3CA
ESR1
AKT
PALB2
ATM
CHEK2
BRCA2
BRCA1
Comprehensive gene panel for breast cancer routine testing
OncoAtlas ABC Plus
NGS tests for clinical oncology compatible with Illumina® and MGI® sequencers
HDAC2
HOXB13
FANCA
RAD54L
RAD51D
RAD51C
RAD51B
PALB2
FANKL
CHEK2
CHEK1
CDK12
BRIP1
BARD1
ATM
BRCA2
BRCA1
Full list of HRR genes for PARPi CDx testing
OncoAtlas HRR
IDH1
MET
MSI
PIK3CA
PDGFRA
TP53
ALK
UGT1A1
DPYD
HRAS
NRAS
KRAS
KIT
IDH2
ERBB2
EGFR
BRAF
Clinically relevant driver genes for solid tumors — FFPE and Liquid biopsy compatible
OncoAtlas Driver
PTEN
Integrated ranking of findings using the ESCAT levels of evidence
The option to modify the automated interpretation of results with an integrated report revision feature
Interpretation according to NCCN, ESMO, ASCO and local guidelines
Select what to include in your report: customizable report settings enable you to optimize fully automated interpretations according to your needs
Linking physicians with laboratories to provide direct access to NGS reports
Software for NGS data analysis that converts raw data into a ready-to-use report featuring clinically relevant insights
AVES software: our data processing solution
France
Italy
China
Kazakhstan
Armenia
USA
UK
France
Italy
China
Kazakhstan
Armenia
USA
UK
France
Italy
China
Kazakhstan
Armenia
USA
UK
France
Italy
China
Kazakhstan
Armenia
USA
UK
Our experience of scientific collaborations
Scientific excellence
More than 40 publications, guidelines and conference abstracts published over the past 5 years
2023
Microsatellite Instability: A Review of Molecular Epidemiology and Implications for Immune Checkpoint Inhibitor Therapy
2023
Microsatellite Instability Detection: The Current Standards, Limitations, and Misinterpretations
2023
Precision oncology strategy in cetuximab-resistant ERRFI1-mutant colon cancer: case report of disease progression on afatinib
Get a consultation
Fill in the fields and we will contact you